Rituximab Patients Should Guard Against Mosquito and Tick Bites as CDC Flags Risk of Severe Brain Infection

A CDC health advisory says B-cell depleting drugs such as rituximab raise the risk of severe arboviral disease. Here is what patients should do.

Have A Referral?